Linked e-resources
Details
Table of Contents
Part 1. Control of Energy Metabolism
1. A Primer on Carbohydrate Metabolism in the Heart
2. Lipoproteins: A Source of Cardiac Lipids
3. Role of Lipoprotein Lipase in Fatty Acid Delivery to the Heart
4. Control of Myocardial Fatty Acid Uptake
5. Cardiac Energy Metabolism in Heart Failure Associated with Obesity and Diabetes
6. Transcriptional Control of Mitochondrial Biogenesis and Maturation
7. Relationship between Substrate Metabolism and Cardiac Efficiency
8. Acetylation in the Control of Mitochondrial Metabolism and Integrity
Part 2. Alteration in Energy Metabolism
9. Adrenergic Control of Cardiac Fatty Acid Oxidation in Diabetes
10. The Myocardial Creatine Kinase System in the Normal, Ischaemic and Failing Heart
11. Fuel Metabolism Plasticity in Pathological Cardiac Hypertrophy and Failure
12. Defects in Mitochondrial Oxidative Phosphorylation in Hearts Subjected to Ischemia-Reperfusion Injury
13. The Role of AMPK in the Control of Cardiac Hypertrophy
14. The Role of Incomplete Fatty Acid Oxidation in the Development of Cardiac Insulin Resistance
Part 3. Optimization of Energy Metabolism
15. Metabolic Therapy for the Ischemic Heart
16. Inhibition of Fatty Acid Oxidation to Treat Heart Failure in Patients
17. Cardiac Metabolic Protection for the Newborn Heart
18. Targeting Transcriptional Control of Fatty Acid Oxidation to Treat Heart Disease.
1. A Primer on Carbohydrate Metabolism in the Heart
2. Lipoproteins: A Source of Cardiac Lipids
3. Role of Lipoprotein Lipase in Fatty Acid Delivery to the Heart
4. Control of Myocardial Fatty Acid Uptake
5. Cardiac Energy Metabolism in Heart Failure Associated with Obesity and Diabetes
6. Transcriptional Control of Mitochondrial Biogenesis and Maturation
7. Relationship between Substrate Metabolism and Cardiac Efficiency
8. Acetylation in the Control of Mitochondrial Metabolism and Integrity
Part 2. Alteration in Energy Metabolism
9. Adrenergic Control of Cardiac Fatty Acid Oxidation in Diabetes
10. The Myocardial Creatine Kinase System in the Normal, Ischaemic and Failing Heart
11. Fuel Metabolism Plasticity in Pathological Cardiac Hypertrophy and Failure
12. Defects in Mitochondrial Oxidative Phosphorylation in Hearts Subjected to Ischemia-Reperfusion Injury
13. The Role of AMPK in the Control of Cardiac Hypertrophy
14. The Role of Incomplete Fatty Acid Oxidation in the Development of Cardiac Insulin Resistance
Part 3. Optimization of Energy Metabolism
15. Metabolic Therapy for the Ischemic Heart
16. Inhibition of Fatty Acid Oxidation to Treat Heart Failure in Patients
17. Cardiac Metabolic Protection for the Newborn Heart
18. Targeting Transcriptional Control of Fatty Acid Oxidation to Treat Heart Disease.